Shopping Cart
- Remove All
Your shopping cart is currently empty
3-Hydroxypyridine exhibits inhibitory activity against DNA topoisomerase 2-beta (Topo IIβ) and HIV-1 replication in Sup-T1 cells, making it useful for studying the HIV-1 virus.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 25 g | $29 | In Stock |
| Description | 3-Hydroxypyridine exhibits inhibitory activity against DNA topoisomerase 2-beta (Topo IIβ) and HIV-1 replication in Sup-T1 cells, making it useful for studying the HIV-1 virus. |
| Targets&IC50 | MIA PaCa-2 cells:56480 nM |
| In vitro | Treatment of HaCaT keratinocytes with 3-Hydroxypyridine (100 μM, 3 days) and subsequent exposure to solar-simulated light inhibited proliferation and induced cell cycle arrest and apoptosis. [1] |
| Molecular Weight | 95.1 |
| Formula | C5H5NO |
| Cas No. | 109-00-2 |
| Smiles | OC=1C=NC=CC1 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 100 mg/mL (1051.52 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 4 mg/mL (42.06 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.